Babesia canis infection in canine-red blood cell-substituted SCID mice.
We have developed a mouse model for Babesia canis infection using severe combined immunodeficiency (SCID) mice whose circulating red blood cells had been substituted with canine red blood cells. Substitution of red blood cells in SCID mice was achieved by repetitive transfusions of canine red blood cells, together with administration of an antimouse red blood cell monoclonal antibody. Following inoculation of canine-red blood cell-SCID mice with B. canis, parasites proliferated in the canine red blood cells that had been transfused into the SCID mice, resulting in much higher parasitaemia than that observed in dogs. In an attempt to demonstrate the utility of this mouse model, three antiprotozoal drugs, diminazene diaceturate, clindamycin and oxytetracycline, were examined for their efficacy to inhibit the growth of B. canis in canine-red blood cell-SCID mice. The mouse model clearly showed that diminazene diaceturate and oxytetracycline were capable of eliminating B. canis from the canine-red blood cell-SCID mice, whereas clindamycin exhibited only a static effect as parasitaemia relapsed upon cessation of drug administration.
Arai
S
S
School of Veterinary Medicine, Rakuno-gakuen University, Ebetsu, Japan.
Tsuji
M
M
Kim
S J
SJ
Nakade
T
T
Kanno
Y
Y
Ishihara
C
C
D000279:Administration, Cutaneous; D000818:Animals; D000911:Antibodies, Monoclonal; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D001403:Babesia / Q000187:drug effects / Q000254:growth & development*; D001404:Babesiosis / Q000097:blood* / Q000188:drug therapy; D002417:Cattle; D002981:Clindamycin / Q000627:therapeutic use; D004133:Diminazene / Q000627:therapeutic use; D004283:Dog Diseases / Q000097:blood* / Q000188:drug therapy; D004285:Dogs; D017707:Erythrocyte Transfusion / Q000662:veterinary; D004912:Erythrocytes / Q000469:parasitology*; D005260:Female; D005434:Flow Cytometry; D008297:Male; D051379:Mice; D016513:Mice, SCID; D010118:Oxytetracycline / Q000627:therapeutic use; D018512:Parasitemia / Q000188:drug therapy / Q000662:veterinary*; D011528:Protozoan Infections / Q000097:blood / Q000188:drug therapy; D011529:Protozoan Infections, Animal
D000911:Antibodies, Monoclonal; D000981:Antiprotozoal Agents; D002981:Clindamycin; D010118:Oxytetracycline; D004133:Diminazene